Nombre del producto:2,4-dichloropyrimidine-5-carbonyl chloride

IUPAC Name:2,4-dichloropyrimidine-5-carbonyl chloride

CAS:2972-52-3
Fórmula molecular:C5HCl3N2O
Pureza:95%+
Número de catálogo:CM100730
Peso molecular:211.43

Unidad de embalaje Stock disponible Precio($) Cantidad
CM100730-5g in stock ƴŤǙ
CM100730-10g in stock ħǙǙ
CM100730-25g in stock ŤƚŮ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2972-52-3
Fórmula molecular:C5HCl3N2O
Punto de fusión:-
Código de sonrisas:O=C(Cl)C1=CN=C(Cl)N=C1Cl
Densidad:1.675g/cm3
Número de catálogo:CM100730
Peso molecular:211.43
Punto de ebullición:304.3°C at 760 mmHg
Nº Mdl:MFCD09742432
Almacenamiento:Store at 2-8°C.

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Cerdulatinib
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).

Related Products